Skye Bioscience, Inc. Quarterly report pursuant to Section 13 or 15(d)

NOTES RECEIVABLE (Parentheticals) (Details) (Independent contractor, USD $)	9 Months Ended
	Jul. 31, 2014
10% Secured promissory note receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maturity period of note receivable	18 months
Promissory note receivable, face amount	$ 18,000
Notes receivable, interest rate	10.00%
Notes received for sale of equipment	18,000
Notes receivable, weekly payments	258.75
Unsecured promissory note receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Promissory note receivable, face amount	4,300
Notes receivable, weekly payments	268.75
8% Secured promissory note receivable
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maturity period of note receivable	1 year
Promissory note receivable, face amount	11,000
Notes receivable, interest rate	8.00%
Notes received for sale of equipment	22,000
Notes receivable, weekly payments	228.46
10% Secured promissory note receivable two
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maturity period of note receivable	1 year
Promissory note receivable, face amount	7,500
Notes receivable, interest rate	10.00%
Notes received for sale of equipment	7,500
Notes receivable, weekly payments	$ 144.23